BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 16108884)

  • 1. Response to neoadjuvant therapy for rectal cancer: influence on long-term results.
    Biondo S; Navarro M; Marti-Rague J; Arriola E; Pares D; Del Rio C; Cambray M; Novell V
    Colorectal Dis; 2005 Sep; 7(5):472-9. PubMed ID: 16108884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative chemoradiotherapy improves local recurrence free survival in locally advanced rectal cancer.
    Tural D; Ozturk M; Selcukbiricik F; Yildiz O; Elicin O; Turna H; Guney S; Ozguroglu M
    J BUON; 2013; 18(2):385-90. PubMed ID: 23818350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].
    Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308
    [No Abstract]   [Full Text] [Related]  

  • 4. Neoadjuvant Chemoradiation for Rectal Cancer Achieves Satisfactory Tumour Regression and Local Recurrence - Result of a Dedicated Multi-disciplinary Approach from a South Asian Centre.
    Deen R; Ediriweera DS; Thillakaratne S; Hewavissenthi J; Kumarage SK; Chandrasinghe PC
    BMC Cancer; 2023 May; 23(1):400. PubMed ID: 37142979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Predictors of Recurrence in Patients with Lower Rectal Cancer Undergoing Neoadjuvant Chemotherapy: A Direct Comparison of Short-Course and Long-Course Chemoradiotherapy.
    Yamamoto A; Toiyama Y; Okugawa Y; Saigusa S; Ide S; Fujikawa H; Hiro J; Yasuda H; Yoshiyama S; Ohi M; Araki T; Kusunoki M
    Oncology; 2019; 96(2):70-78. PubMed ID: 30227430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can increasing the dose of radiation by HDR brachytherapy boost following pre operative chemoradiotherapy for advanced rectal cancer improve surgical outcomes?
    Sun Myint A; Mukhopadhyay T; Ramani VS; Perkins K; Snee AJ; Jelley F; Wong H; Lee CD
    Colorectal Dis; 2010 Aug; 12 Suppl 2():30-6. PubMed ID: 20618365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncologically safe distal resection margins in rectal cancer patients treated with chemoradiotherapy.
    Kwak JY; Kim CW; Lim SB; Yu CS; Kim TW; Kim JH; Jang SJ; Kim JC
    J Gastrointest Surg; 2012 Oct; 16(10):1947-54. PubMed ID: 22878788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of neoadjuvant chemoradiotherapy followed by total mesorectal excision surgery for locally advanced rectal cancer: a single-institution experience.
    Tseng MSF; Zheng H; Ng IWS; Leong YH; Leong CN; Yong WP; Cheong WK; Tey JCS
    Singapore Med J; 2018 Jun; 59(6):305-310. PubMed ID: 29167909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complete pathologic response following preoperative chemoradiation therapy for middle to lower rectal cancer is not a prognostic factor for a better outcome.
    Pucciarelli S; Toppan P; Friso ML; Russo V; Pasetto L; Urso E; Marino F; Ambrosi A; Lise M
    Dis Colon Rectum; 2004 Nov; 47(11):1798-807. PubMed ID: 15622571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is final TNM staging a predictor for survival in locally advanced rectal cancer after preoperative chemoradiation therapy?
    Kuo LJ; Liu MC; Jian JJ; Horng CF; Cheng TI; Chen CM; Fang WT; Chung YL
    Ann Surg Oncol; 2007 Oct; 14(10):2766-72. PubMed ID: 17551794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transanal Endoscopic Microsurgery (TEM) Following Neoadjuvant Chemoradiation for Rectal Cancer: Outcomes of Salvage Resection for Local Recurrence.
    Perez RO; Habr-Gama A; São Julião GP; Proscurshim I; Fernandez LM; de Azevedo RU; Vailati BB; Fernandes FA; Gama-Rodrigues J
    Ann Surg Oncol; 2016 Apr; 23(4):1143-8. PubMed ID: 26577119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized phase III study comparing preoperative radiotherapy with chemoradiotherapy in nonresectable rectal cancer.
    Braendengen M; Tveit KM; Berglund A; Birkemeyer E; Frykholm G; Påhlman L; Wiig JN; Byström P; Bujko K; Glimelius B
    J Clin Oncol; 2008 Aug; 26(22):3687-94. PubMed ID: 18669453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low rectal cancer: impact of radiation and chemotherapy on surgical treatment.
    Habr-Gama A; de Souza PM; Ribeiro U; Nadalin W; Gansl R; Sousa AH; Campos FG; Gama-Rodrigues J
    Dis Colon Rectum; 1998 Sep; 41(9):1087-96. PubMed ID: 9749491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consolidation mFOLFOX6 Chemotherapy After Chemoradiotherapy Improves Survival in Patients With Locally Advanced Rectal Cancer: Final Results of a Multicenter Phase II Trial.
    Marco MR; Zhou L; Patil S; Marcet JE; Varma MG; Oommen S; Cataldo PA; Hunt SR; Kumar A; Herzig DO; Fichera A; Polite BN; Hyman NH; Ternent CA; Stamos MJ; Pigazzi A; Dietz D; Yakunina Y; Pelossof R; Garcia-Aguilar J;
    Dis Colon Rectum; 2018 Oct; 61(10):1146-1155. PubMed ID: 30192323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Korean Society of Coloproctology (KSCP) trial of cONsolidation Chemotherapy for Locally advanced mid or low rectal cancer after neoadjUvant concurrent chemoraDiothErapy: a multicenter, randomized controlled trial (KONCLUDE).
    Kim CW; Kang BM; Kim IY; Kim JY; Park SJ; Park WC; Bae KB; Bae BN; Baek SK; Baik SH; Son GM; Lee YS; Lee SH
    BMC Cancer; 2018 May; 18(1):538. PubMed ID: 29739356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of clinical and pathological stages on locally advanced rectal carcinoma after neoadjuvant chemoradiotherapy.
    Wen B; Zhang L; Wang C; Huang R; Peng H; Zhang T; Dong J; Xiao W; Zeng Z; Liu M; Gao Y
    Radiat Oncol; 2015 Jun; 10():124. PubMed ID: 26040453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction chemotherapy before chemoradiotherapy and surgery for locally advanced rectal cancer : is it time for a randomized phase III trial?
    Rödel C; Arnold D; Becker H; Fietkau R; Ghadimi M; Graeven U; Hess C; Hofheinz R; Hohenberger W; Post S; Raab R; Sauer R; Wenz F; Liersch T
    Strahlenther Onkol; 2010 Dec; 186(12):658-64. PubMed ID: 21136027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer using 18FDG-PET/CT.
    Shanmugan S; Arrangoiz R; Nitzkorski JR; Yu JQ; Li T; Cooper H; Konski A; Farma JM; Sigurdson ER
    Ann Surg Oncol; 2012 Jul; 19(7):2178-85. PubMed ID: 22395978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of risk factors of distant metastasis in rectal cancer patients who received total mesorectal excision following neoadjuvant chemoradiotherapy].
    Sun Y; Chi P; Lin H; Lu X; Huang Y; Xu Z; Huang S; Ye D; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Apr; 19(4):436-41. PubMed ID: 27112480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant Chemotherapy in Rectal Cancer Patients Treated With Preoperative Chemoradiation and Total Mesorectal Excision: A Multicenter and Retrospective Propensity-Score Matching Study.
    Chung MJ; Lee JH; Lee JH; Kim SH; Song JH; Jeong S; Yu M; Nam TK; Jeong JU; Jang HS
    Int J Radiat Oncol Biol Phys; 2019 Feb; 103(2):438-448. PubMed ID: 30244158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.